Profile data is unavailable for this security.
About the company
Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.
- Revenue in CAD (TTM)57.98m
- Net income in CAD-19.39m
- Incorporated2015
- Employees195.00
- LocationEvome Medical Technologies Inc49 Natcon DriveSHIRLEY 11967United StatesUSA
- Websitehttps://www.evomemedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lattice Biologics Ltd | 2.19m | -1.34m | 4.24m | -- | -- | -- | -- | 1.93 | -0.0105 | -0.0105 | 0.0172 | 0.0011 | 1.01 | 3.83 | 8.70 | -- | -61.69 | -- | -- | -- | 28.53 | -- | -61.08 | -- | 0.00 | -1.02 | 0.00 | -- | 12.60 | -- | -46.52 | -- | -- | -- |
| SQI Diagnostics Inc | 3.04m | -19.13m | 6.18m | 55.00 | -- | -- | -- | 2.03 | -0.0483 | -0.0483 | 0.0077 | -0.035 | 0.286 | 3.23 | 3.91 | -- | -179.74 | -147.99 | -- | -264.33 | 10.97 | 48.25 | -628.52 | -400.28 | 0.1193 | -3.03 | 24.07 | -- | 783.53 | 52.95 | -75.46 | -- | 42.57 | -- |
| Kovo+Holdings Inc | 15.17m | -7.66m | 7.99m | -- | -- | -- | -- | 0.5264 | -0.133 | -0.133 | 0.2636 | -0.0781 | 1.17 | -- | 48.85 | -- | -58.91 | -- | -242.80 | -- | -- | -- | -50.45 | -- | -- | -1.23 | 1.51 | -- | -5.04 | -- | -1,773.60 | -- | -- | -- |
| Evome Medical Technologies Inc | 57.98m | -19.39m | 8.37m | 195.00 | -- | -- | -- | 0.1444 | -0.2425 | -0.2425 | 0.6601 | -0.0279 | 1.07 | 3.21 | 6.91 | 297,326.20 | -35.78 | -- | -144.36 | -- | 34.58 | -- | -33.45 | -- | 0.2596 | -1.94 | 1.14 | -- | -- | -- | -- | -- | -- | -- |
| Cloud DX Inc | 2.07m | -9.87m | 12.09m | -- | -- | -- | -- | 5.82 | -0.1052 | -0.1052 | 0.0222 | -0.238 | 0.9711 | 1.23 | 8.32 | -- | -461.80 | -- | -- | -- | 89.94 | -- | -475.56 | -- | 0.0546 | -1.57 | -- | -- | 55.39 | -- | 2.56 | -- | -- | -- |
| H-Source Holdings Ltd | 682.93k | -3.32m | 12.16m | -- | -- | -- | -- | 17.81 | -0.0282 | -0.0282 | 0.0058 | -0.0547 | 0.496 | 10.49 | 5.07 | -- | -241.05 | -300.92 | -- | -1,550.02 | 10.55 | -- | -485.95 | -613.68 | 0.0134 | -2.61 | -- | -- | -51.99 | -- | 3.93 | -- | -- | -- |
